Home > Boards > US Listed > Telecommunications Hardware > ADC Telecommunications (ADCT)

This is the first post here in over

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
OldAIMGuy Member Profile
Member Level 
Followed By 113
Posts 14,275
Boards Moderated 6
Alias Born 01/29/02
160x600 placeholder
ADC Therapeutics erhält Orphan-Drug-Status in Europa für ZYNLONTA® Business Wire - 9/13/2021 9:36:00 PM
ADC Therapeutics a reçu la désignation de médicament orphelin en Europe pour ZYNLONTA® Business Wire - 9/13/2021 8:36:00 AM
ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA® Business Wire - 9/13/2021 7:15:00 AM
ADC Therapeutics participera à la 19e conférence annuelle mondiale sur les soins de santé de Morgan Stanley Business Wire - 9/9/2021 1:55:00 PM
ADC Therapeutics nimmt an der 19. jährlichen globalen Gesundheitskonferenz von Morgan Stanley teil Business Wire - 9/9/2021 8:47:00 AM
ADC Therapeutics to Participate in Morgan Stanley’s 19th Annual Global Healthcare Conference Business Wire - 9/9/2021 7:15:00 AM
ADC Therapeutics gibt Wechsel in der medizinischen Führungsspitze bekannt Business Wire - 9/3/2021 3:12:00 PM
ADC Therapeutics annonce une transition au niveau de sa direction médicale Business Wire - 9/3/2021 9:38:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:22:53 AM
ADC Therapeutics Announces Medical Leadership Transition Business Wire - 9/3/2021 7:15:00 AM
ADC Therapeutics schließt Finanzierungsvereinbarung mit HealthCare Royalty im Umfang von bis zu 325 Millionen US-Dollar ab Business Wire - 8/26/2021 7:05:00 PM
ADC Therapeutics conclut un accord de financement avec HealthCare Royalty pour un montant pouvant aller jusqu'à 325 millions USD Business Wire - 8/26/2021 3:42:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/26/2021 8:35:26 AM
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million Business Wire - 8/26/2021 7:15:00 AM
ADC Therapeutics publie ses résultats financiers pour le deuxième trimestre 2021 et fait le point sur ses activités Business Wire - 8/4/2021 9:27:00 AM
ADC Therapeutics gibt Finanzergebnisse für das zweite Quartal 2021 und aktuelle Unternehmensentwicklungen bekannt Business Wire - 8/3/2021 11:13:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/3/2021 7:08:26 AM
ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates Business Wire - 8/3/2021 7:00:00 AM
ADC Therapeutics veranstaltet am 3. August 2021 eine Telefonkonferenz zu den Finanzergebnissen des 2. Quartals 2021 Business Wire - 7/29/2021 2:26:00 AM
ADC Therapeutics organise le 3 août 2021 une conférence téléphonique sur ses résultats financiers du deuxième trimestre 2021 Business Wire - 7/29/2021 2:26:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/28/2021 5:09:20 PM
ADC Therapeutics to Host Second Quarter 2021 Financial Results Conference Call on August 3, 2021 Business Wire - 7/28/2021 4:56:00 PM
ADC Therapeutics: Auf der 16. jährlichen International Conference on Malignant Lymphoma wurden vielversprechende Zwischenerg... Business Wire - 6/22/2021 11:08:00 PM
ADC Therapeutics annonce que les résultats provisoires encourageants de l'essai clinique pivot de Phase 2 sur le camidanluma... Business Wire - 6/22/2021 11:05:00 PM
ADC Therapeutics updates interim data in mid-stage Hodgkin lymphoma study Seeking Alpha - 6/22/2021 10:28:38 AM
OldAIMGuy Member Level  Wednesday, 01/31/07 10:39:44 AM
Re: None
Post # of 46 
This is the first post here in over a year. Well, the news is good, so that warrants posting.

http://biz.yahoo.com/bizj/070129/1409983.html?.v=1

ADCT's efforts of a few years ago are providing a bit of a windfall for them now.

The company has earnings again and a P/E that's not in nosebleed territory right now. In the lower half of its 52 week range, it should have some reasonable support going forward.



The cyclical nature of the Telecomm industry makes this a trade-able stock for ST traders as well as longer term AIM users.

Best regards, Tom




Port Washington, WI 53074
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences